HCV NS5A inhibits interferon-α signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines
Open Access
- 14 December 2006
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 46 (5) , 759-767
- https://doi.org/10.1016/j.jhep.2006.11.013
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mechanisms of type-I- and type-II-interferon-mediated signallingNature Reviews Immunology, 2005
- Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infectionJournal of Viral Hepatitis, 2001
- The non‐structural 5A protein of hepatitis C virusJournal of Viral Hepatitis, 1999
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Mutations in the Nonstructural Protein 5a Gene and Response to Interferon in Patients with Chronic Hepatitis C Virus 1b InfectionNew England Journal of Medicine, 1996
- Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in JapanHepatology, 1995
- Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.Journal of Clinical Investigation, 1995
- A protein tyrosine kinase in the interferon αβ signaling pathwayCell, 1992
- Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proceedings of the National Academy of Sciences, 1990
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989